Mayday Industries Inc. – Trademark Portfolio
Entity Type: 03
Mayday Industries Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MAYDAY and MAYDAY INDUSTRIES. The owner is based in Westminister, CA.
15158 Goldenwest Cir.
Westminister, CA 92683
Showing of trademarks Trademarks
Trademark Classifications
Mayday Industries Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Mayday Industries Inc. have?
Mayday Industries Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.
What trademark classes does Mayday Industries Inc. file in?
Mayday Industries Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Mayday Industries Inc.'s most well-known trademarks?
Mayday Industries Inc.'s registered trademark portfolio includes well-known marks such as MAYDAY and MAYDAY INDUSTRIES. These are among 2 currently registered trademarks in the portfolio.
What is Mayday Industries Inc.'s trademark registration success rate?
Mayday Industries Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.